rs11096688 - LINC02850 - APOB
Magnitude 2.8 · 1 study on file
Reported associations
-
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer - Unknown journal (n.d.) · Unknown authors · PubMed 31371054
ABSTRACT: Objective: To study how genetics may play a role in determining risk of chemotherapy-related amenorrhea (CRA) in young women with breast cancer. Design: A genome-wide association study Setting: A pooled cohort including participants in three clinical trials (SUCCESS A, B or C) testing chemotherapy for early stage breast cancer Patients: Premenopausal women ≤45 years enrolled in one of these three trials were included if they had at least one menstrual case report form after chemotherapy ended, and if they were of European ancestry. Forms during and up to three months after receipt of gonadotropin-releasing hormone agonist were excluded. Intervention(s): None Main Outcomes Measure(s): The association of single nucleotide polymorphisms (SNPs) with post-chemotherapy menstruation a
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.